ch
22, Fool.com contributors Brian Orelli and Keith Speights discuss whether $500 million will be enough and what the SPAC can do to help boost the capital available to whatever company it eventually decides to take public.
Brian Orelli: Revolution Healthcare Acquisition Corp. only raised $500 million, which, to be honest, isn t a whole lot of money for a biotech these days. Do you think they can find something that cheap. You can talk about the other mechanisms that SPACs use to bolster their investments beyond with this SPAC actually has in cash.
Keith Speights: Yeah, I think that s the really big question here. Will Revolution Healthcare, first of all, be able to find any company that really meet their vision of what they re trying to achieve here, and can they do it for $500 million? That s going to be hard, I think. To do so, they might have to find some really early stage companies, again, that just introduces more risk to the equation. But you re right, $500 million is not